Stakeholder Workshop 2013

Download the presentations given at the Stakeholder workshop held in January 2013 at Copenhagen Airport Kastrup.

Agenda Nordic Trial Alliance stakeholders workshop January 31, 2013

Anders Ekblom, AstraZeneca R&D: A big pharma perspective on clinical research with reflections on the Nordic region - threats and opportunities

Olav Flaten, MD, PhD, GlaxoSmithKline and NRI-networks: Reinforcing collaboration between academia and industry

Christian Gluud,Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital and Siv Mørkved, Trondheim University Hospital: Success factors for Nordic clinical trials

Pétur S. Gunnarsson, Landspitali University Hospital: Clinical research requires increased attention

Gunnel Gustafsson, Director NordForsk: NordForsk

Nicolai Haase, MD, ph.d.-student, 6S-trial coordinator, Copenhagen University Hospital: Success Factors for Nordic Clinical Trials

Annette Jørgensen: Success factors for Nordic collaborations

Pierre Lafolie, MD, PhD, Dep of Medicine, Clincal Pharmacology, Karolinska Institutet: Nordic Trial Alliance
an initiative to strengthen Nordic clinical research

Prof. Jan-Eric Litton, Karolinska Institutet, Stockholm, Sweden: Success factors for Nordic collaborations BBMRI.nordic Initiative

Prof. Ruairidg Milne, NIHR Evaluation, Trials and Studies Coordination Centre, University of Southampton: Clinical Trials for health and wealth: the experience of NIHR since 2006

Professor Tuula Tamminen, Chair of NOS-M: NOS-M and Nordic Medical Research

Eszter Vanky, Associate professor, MD PhD, Dept. of Obstetrics and Gynecology, St.Olavs Hospital, Trondheim, Dept. of Laboratory Medicine, Women´s and Children´s Health, Norwegian University of Science and Technology, Trondheim: Success factors for Nordic Clinical Trials

The Nordic Trial Alliance (NTA) is a project that aims to facilitate clinical research cooperation in the Nordic region. It is funded by the Nordic Council of Ministers and NordForsk.